Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

Description

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sally Meade

Dr Sally Meade

Work Up of a Breast Lump in GP – Practical Tips and Traps

Dr Gary Deed

Dr Gary Deed

Semaglutide – Which Dose for Which Patient?

Dr Andrew Scroop

Dr Andrew Scroop

Triple Therapy in Asthma – Case Studies in Primary Care

Prof Paul Griffin

Prof Paul Griffin

RSV Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Peter Richmond

expert

Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician; Perth Children’s Hospital; Head of the Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases

Date published: 21 June 2022